Stocktoria
CHAMPIONS ONCOLOGY, INC. CSBR
Nasdaq · XNAS · stock · Biological Products, (No Diagnostic Substances) · website · IPO 1988-11-30
CHAMPIONS ONCOLOGY, INC. financials (annual, from 10-K)
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | $56.9M | $50.2M | $53.9M | $49.1M | $41.0M |
| R&D expense | $6.8M | $9.5M | $11.5M | $9.4M | $7.2M |
| Operating income | $4.6M | -$7.4M | -$5.3M | $607,000 | $366,000 |
| Income tax | -$75,000 | -$32,000 | $68,000 | $35,000 | $75,000 |
| Net income | $4.7M | -$7.3M | -$5.3M | $548,000 | $362,000 |
| EPS (diluted) | $0.33 | $-0.54 | $-0.39 | $0.04 | $0.02 |
| Operating cash flow | $7.4M | -$6.1M | $4.0M | $6.5M | -$1.7M |
| Free cash flow | $7.0M | -$7.0M | $1.1M | $4.1M | -$5.0M |
| Cash & equivalents | $9.8M | $2.6M | $10.1M | $9.0M | $4.7M |
| Total assets | $32.3M | $26.1M | $34.3M | $35.4M | $27.6M |
| Total liabilities | $28.6M | $28.0M | $29.7M | $26.3M | $20.2M |
| Shareholders' equity | $3.8M | -$1.9M | $4.6M | $9.1M | $7.4M |
Source: SEC EDGAR filings · CIK 0000771856 · as of 2025-04-30. Facts from filings plus Stocktoria's own computed scores — not investment advice.